Q5102 Injection, infliximab, biosimilar, 10 mg

Short descriptor: Inj., infliximab biosimilar

⚠ Terminated HCPCS Level II 2026
Terminated Code
Q5102 was terminated as of 2018-03-31 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open Q5102 in the app →

Look up Q5102 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

Q5102 is the HCPCS Level II code for Injection, infliximab, biosimilar, 10 mg (2026). It belongs to Section Q — Temporary Codes. Under Medicare, its coverage status is: Special coverage instructions apply. Part B pricing methodology: Drugs.

Classification & CMS Attributes

Medicare Coverage
Special coverage instructions apply (code D)
Part B Pricing
Drugs (indicator 51)
Type of Service
Medical care
Effective Date
2018-04-01
Termination Date
2018-03-31
2026 Maintenance
No change this year

References

Cite This Page

Reference Q5102 with the canonical source and edition:

Q5102 — Injection, infliximab, biosimilar, 10 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/Q5102

Canonical URL: https://icd10codingpro.com/hcpcs-codes/Q5102

Related Codes in Section Q

← Q5101 Injection, zarxio Q5103 → Injection, inflectra
Q5098 Inj ustekinumab-srlf, 1 mg Q5099 Inj ustekinumab-stba, 1 mg Q5100 Inj ustekinumab-kfce, 1 mg Q5101 Injection, zarxio Q5103 Injection, inflectra Q5104 Injection, renflexis Q5105 Inj retacrit esrd on dialysi Q5106 Inj retacrit non-esrd use Q5107 Inj mvasi 10 mg Q5108 Injection, fulphila
Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial